• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, April 6, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

PATH statement on White House Summit on AI for American Industry

Bioengineer by Bioengineer
May 10, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Mary Ann Liebert, Inc., publishers

May 10, 2018, Washington, DC – The Partnership for Artificial Intelligence and Automation in Healthcare (PATH) applauds today's White House Summit on Artificial Intelligence (AI) for American Industry. AI is a growth area for U.S. businesses and has the potential to revolutionize the delivery of healthcare by improving lives, expanding access, reducing medical errors, and reducing costs. AI can accelerate productivity gains in the healthcare sector and help overcome the overwhelming needs of less-served populations around the world.

"AI and related innovations have already enabled industries such as banking, aviation, and entertainment to grow, provide higher-quality products, and allow consumers greater choice," stated Jonathan Linkous, Co-Founder and CEO of PATH. "With spiraling costs, increasing need, decreasing resources, and rapidly advancing technologies, healthcare desperately needs to catch up."

PATH encourages participants in the meeting to consider ways to remove barriers to AI and related innovations and identify ways to accelerate their integration into healthcare delivery systems including devoting more resources to AI research and development for healthcare.

"The use of AI, robotics, and automation will transform healthcare," said Mary Ann Liebert, Co-Founder of PATH. "There needs to be greater understanding of their application and all of the conundrums; PATH will address these issues so that new technologies are best understood and applied most meaningfully. Our mission is imperative and the leaders in these fields are participating."

###

About PATH

The Partnership for Artificial Intelligence and Automation in Healthcare is a membership-based, mission-driven alliance to ensure the integration of automation, robotics, and artificial intelligence (AI) into the many components of global healthcare services. PATH members include professionals delivering care, health systems, industry, public policy, academia, government, and educators – all of whom have a stake in the delivery of effective healthcare around the world in both on-site and remote care environments. More information is available on the PATH website.

Media Contact

Kathryn Ryan
[email protected]
914-740-2250
@LiebertPub

http://www.liebertpub.com

Share13Tweet8Share2ShareShareShare2

Related Posts

Single Molecule Model Unveils V-ATPase Role in Blastocyst

April 6, 2026

Frailty, Nutrition, Depression Impact Elderly Quality of Life

April 5, 2026

Real-World Safety of Second-Line Diabetes Drugs in Elderly

April 4, 2026

Protein Monitoring Enhances EASO Obesity Care Timing

April 4, 2026
Please login to join discussion

POPULAR NEWS

  • blank

    Revolutionary AI Model Enhances Precision in Detecting Food Contamination

    97 shares
    Share 39 Tweet 24
  • Promising Outcomes from First Clinical Trials of Gene Regulation in Epilepsy

    51 shares
    Share 20 Tweet 13
  • Imagine a Social Media Feed That Challenges Your Views Instead of Reinforcing Them

    1008 shares
    Share 398 Tweet 249
  • Popular Anti-Aging Compound Linked to Damage in Corpus Callosum, Study Finds

    44 shares
    Share 18 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Single Molecule Model Unveils V-ATPase Role in Blastocyst

Overview of Photocatalysts and Biocatalysts in Advancing Artificial Photosynthesis

Japanese Health Promotion Questionnaire: Validity Confirmed

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 78 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.